Live Streaming
Program Highlight
Company Profile
Zona Integritas
Monday, 14 September 2020 13:42

Diplomatic Corner

Written by 
Rate this item
(0 votes)

University of Indonesia (UI) and University of British Columbia Canada (UBC) have agreed to collaborate in the fields of education, research and community service. The agreement was signed directly by Rector of the University of Indonesia, Ari Kuncoro, represented by Deputy Rector Abdul Haris and Vice-Provost International University of British Columbia, Murali Chandrashekaran in Jakarta more recently. Ari Koncoro said at this collaboration is aimed at accelerating relations between institutions, which is finally able to enhance synergy between the two universities, especially in handling the Covid-19 pandemic. Rector Ari Koncoro perceived that the Covid-19 pandemic situation does not stop the University of Indonesia to establish synergy with university partners abroad. Through the sophistication of Information Communication Technology as a backbone amid the ongoing pandemic, UI collaborates with UBC Canada to mutually agree on a number of activities to be carried out such as student exchange programs, visiting scholarships, joint conferences and research collaborations between UI and UBC researchers.

A number of countries keep trying to develop the Covid-19 vaccine. Indonesia through its representatives, the Indonesian Embassy in Tokyo has explored the potential cooperation by visiting Shionogi & Co, a company which runs in research, development and production of vaccines and medical devices that has headquarters in Osaka, Japan. Chargé d'Affaires of the Indonesian Embassy in Tokyo, Tri Purnajaya said that Indonesia eagerly welcomes the vaccine cooperation opportunities, both in terms of research, development, clinical trials and production. Moreover, Indonesia and Japan have agreed to keep strengthening cooperation in overcoming the Covid-19 pandemic. At the same time, an assessment was also carried out with the Osaka University Research Institute for Microbial Diseases (RIMD). RIMD is involved in the Covid-19 vaccine research process in collaboration with the startup pharmaceutical company of the university. In line with Shionogi, Osaka University welcomes the opportunity to cooperate with Indonesia and emphasizes the importance of starting cooperation in education, research, and industry.

Read 710 times Last modified on Tuesday, 15 September 2020 08:21